Treatments | Very high (n=43) | High (n=914) | Moderate (n=283) | Total (n=1240) |
Statin prescriptions | ||||
Statins only | 39 (90.7) | 847 (92.7) | 270 (95.4) | 1156 (93.2) |
Statins with other lipid-lowering drugs | 4 (9.3) | 67 (7.3) | 13 (4.6) | 84 (6.8) |
Type of statins | ||||
Pravastatin | 0 (0.0) | 3 (0.3) | 0 (0.0) | 3 (0.2) |
Simvastatin | 38 (88.4) | 798 (87.3) | 223 (78.8) | 1059 (85.4) |
Atorvastatin | 1 (2.3) | 66 (7.2) | 32 (11.3) | 99 (8.0) |
Rosuvastatin | 4 (9.3) | 47 (5.1) | 28 (9.9) | 79 (6.4) |
Duration (months) of statin treatment | ||||
3–6 | 4 (9.3) | 93 (10.2) | 39 (13.8) | 136 (11.0) |
7–12 | 10 (23.3) | 174 (19.0) | 61 (21.6) | 245 (19.8) |
13–24 | 13 (30.2) | 254 (27.8) | 82 (29.0) | 349 (28.1) |
25–36 | 11 (25.6) | 170 (18.6) | 54 (19.1) | 235 (19.0) |
≥37 | 5 (11.6) | 223 (24.4) | 47 (16.6) | 275 (22.2) |
Field of expertise of the attending physicians | ||||
Internal medicine | 41 (95.3) | 905 (99.0) | 281 (99.3) | 1227 (99.0) |
General | 26 | 755 | 248 | 1029 |
Cardiologist | 13 | 90 | 25 | 128 |
Endocrinologist, nephrologists or neurologist | 2 | 58 | 7 | 67 |
Unspecified | 0 | 2 | 1 | 3 |
Non-internal medicine | 2 (4.7) | 9 (1.0) | 2 (0.7) | 13 (1.0) |
Very-high-risk patients had postmyocardial infarction with diabetes mellitus (DM), poststroke with DM or peripheral artery disease with DM. High-risk patients had coronary artery disease, cardiovascular disease, poststroke or DM. Moderate-risk patients had two or more risks plus either hypertension or dyslipidaemia.